HuGE Literature Finder
Records 1 - 1
| Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.
British journal of cancer 2011 Feb 104 (4): 605-12.
Kim K-p, Jang G, Hong Y S, Lim H-S, Bae K-s, Kim H-S, Lee S S, Shin J-G, Lee J-L, Ryu M-H, Chang H-M, Kang Y-K, Kim T
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: